Similar Search Results

Cross-country evidence on the contributions of research institutions to innovation

Paunov, Caroline; Borowiecki, Martin; El-Mallakh, Nevine - 2019

This paper presents preliminary evidence on the patenting activities of 21 200 research institutions - 20 091 higher education institutions (HEIs) and 1 109 public research institutes (PRIs) - for 36 OECD countries and China from 1992 to 2014. Our evidence, which builds on a database that...

Persistent link: https://www.econbiz.de/10012168868

On the concentration of innovation in top cities in the digital age

Paunov, Caroline; Guellec, Dominique; El-Mallakh, Nevine; … - 2019

innovation in these cities. …

Persistent link: https://www.econbiz.de/10012168905

OECD case study of Norway's digital science and innovation policy and governance landscape

Galindo-Rueda, Fernando; Keenan, Michael; Ker, Daniel; … - 2020

This report describes Norway’s landscape for Digital Science and Innovation Policy (DSIP) - the overarching framework …

Persistent link: https://www.econbiz.de/10012421310

The effects of R&D tax incentives and their role in the innovation policy mix findings from the OECD microBeRD project, 2016-19

Appelt, Silvia; Bajgar, Matej; Criscuolo, Chiara; … - 2020

This report presents new evidence on the impact of R&D tax incentives and direct funding of business R&D, drawing on distributed cross-country and firm-level analyses undertaken as part of the first phase of the OECD microBeRD project (2016-19). This “distributed” approach facilitates a...

Persistent link: https://www.econbiz.de/10012421327

Collaborative platforms for innovation in advanced materials

Kreiling, Laura; Robinson, Douglas K. R.; Winickoff, … - 2020

innovation ecosystems and build education, skills and social capital. …

Persistent link: https://www.econbiz.de/10012421347

Regulatory frameworks for nanotechnology in foods and medical products : summary results of a survey activity

OECD - 2013

Nanotechnology applications have been reported across a number of specific product areas including foods and medical products, which are subject to regulatory oversight in many countries to ensure their safety and, in some cases, effectiveness. As nanotechnology develops, countries/regions have...

Persistent link: https://www.econbiz.de/10011632277

Nanotechnology for green innovation

OECD - 2013

on Nanotechnology (WPN) relevant to the development and use of nanotechnology for green innovation. It relies in …

Persistent link: https://www.econbiz.de/10011632278

Emerging trends in biomedicine and health technology innovation : addressing the global challenge of Alzheimer's

OECD - 2013

The economic and social impact of chronic brain disorders (CBD) such as Alzheimer’s disease (AD) and other neurodegenerative diseases will become the number one public-health problem worldwide, directly affecting 100 million people by 2050. On-going demographic trends, namely ageing...

Persistent link: https://www.econbiz.de/10011632279

Toward new models for innovative governance of biomedicine and health technologies

OECD - 2013

communities involved in the translation of biomedical innovation and health technologies from the laboratory bench to point of …

Persistent link: https://www.econbiz.de/10011632331

Public-private partnerships in biomedical research and health innovation for Alzheimer's disease and other dementias

OECD - 2015

, undertook a project on “Healthy Ageing and Biomedical Innovation for Dementia and Alzheimer’s disease”. The project was … strengthen effective co-operation at a global level for the governance of biomedical technologies and health innovation in … collaboration for innovation and cross-sector partnerships focused on social impact investment, new care and prevention models, and …

Persistent link: https://www.econbiz.de/10011632355